— Know what they know.
Not Investment Advice

ISPC NASDAQ

iSpecimen Inc.
1W: -17.5% 1M: -30.2% 3M: -59.5% YTD: -90.9% 1Y: -97.9% 3Y: -99.8% 5Y: -100.0%
$1.08
-0.06 (-5.26%)
 
Weekly Expected Move ±7.9%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 30 · $2.7M mcap · 3M float · 21.01% daily turnover · Short 26% of daily vol

Balance Sheet Trends

Total Assets
$9M -40.9% ▼
5Y CAGR: +17.3%
Total Liabilities
$6M -0.6% ▼
5Y CAGR: -25.8%
Shareholders Equity
$3M -66.0% ▼
Cash & Investments
$2M -62.5% ▼
5Y CAGR: +103.4%
Total Debt
$312K +59.1% ▲
5Y CAGR: -50.6%
Net Debt
-$2M +27.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$696K$28M$15M$2M$2M
Short-Term Investments$0$0$0$3M$0
Cash & ST Investments$696K$28M$15M$5M$2M
Net Receivables$2M$5M$4M$3M$1M
Inventory$0$0$0$0$0
Other Current Assets$0$0$141K$292K$265K
Total Current Assets$3M$33M$20M$8M$4M
Property, Plant & Equip.$76K$33K$411K$322K$422K
Goodwill & Intangibles$3M$3M$5M$7M$5M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$28K$28K$28K$28K$12K
Total Non-Current Assets$3M$3M$5M$8M$6M
Total Assets$6M$36M$25M$16M$9M
— Liabilities —
Accounts Payable$2M$833K$2M$4M$4M
Short-Term Debt$13M$0$0$0$0
Deferred Revenue$873K$655K$0$416K$361K
Other Current Liabilities$2M$0$132K$0$0
Total Current Liabilities$22M$3M$4M$6M$6M
Long-Term Debt$179K$3M$0$0$0
Other Non-Current Liab.$11M$0$0$0$0
Total Non-Current Liabilities$11M$3M$27K$29K$269K
Total Liabilities$33M$6M$4M$6M$6M
— Equity —
Common Stock$94$873$892$908$170
Retained Earnings-$29M-$38M-$48M-$59M-$72M
Accumulated OCI$0$0$0$840$0
Total Stockholders Equity-$27M$30M$20M$10M$3M
Total Liabilities & Equity$6M$36M$25M$16M$9M
— Key Metrics —
Total Debt$13M$3M$186K$196K$312K
Net Debt$12M-$24M-$15M-$2M-$2M
Total Investments$0$0$0$3M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms